July 20, 2015. In recent years, immunotherapy has emerged as a promising treatment for certain cancers. Now this strategy, which uses patients' own immune cells, genetically engineered to target tumors, has shown significant ...
Jul 20, 2015
0
45
Screening mammography volumes have not returned to pre-COVID-19 levels, according to a study published online June 8 in the Journal of the American College of Radiology.
Jun 10, 2022
0
5
(HealthDay)—Millions of Americans take low-dose aspirin every day for heart health. In doing so, they may also slightly lower their risk of dying from several cancers, a large new study suggests.
Apr 3, 2017
0
2
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited. ...
Jan 18, 2012
0
0
Medical investigators at the Virginia G. Piper Cancer Center at Scottsdale Healthcare are studying a new cancer immunotherapy to see if it can successfully help patients with advanced pancreatic cancer.
Jun 13, 2014
0
1
Researchers from University Hospitals Case Medical Center have published findings that a new form of imaging—PET/MRI—is promising for several types of cancer. In an article titled "PET/MRI: Applications in Clinical Imaging," ...
Aug 29, 2013
0
0
Researchers at Moffitt Cancer Center are in the first phase of creating "designer lymph nodes." Designer lymph nodes are built with specialized gene-modified cells that are injected into patients and produce a pre-planned ...
Apr 29, 2012
0
0
A new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year clinical trial at the University of Colorado Cancer Center.
Dec 16, 2022
0
29
Scientists at Sanford Burnham Prebys have identified the long-sought structure of an essential blood protein: vitronectin. Knowing the protein's structure—an advance that enables rational drug design—could lead to medicines ...
Sep 12, 2019
0
142
Cancer treatments have long been moving toward personalization—finding the right drugs that work for a patient's unique tumor, based on specific genetic and molecular patterns. Many of these targeted therapies are highly ...
Mar 17, 2023
0
60
